ID

16672

Descrizione

Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20); ODM derived from: https://clinicaltrials.gov/show/NCT00310232

collegamento

https://clinicaltrials.gov/show/NCT00310232

Keywords

versioni (1)
  1. 31/07/16 31/07/16 -
Caricato su

31 luglio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Non-Small-Cell Lung Carcinoma NCT00310232

Inglese

Eligibility Non-Small-Cell Lung Carcinoma NCT00310232

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. histologically confirmed non-small cell lung cancer (squamous cell, large cell, adenocarcinoma, or some combination of these), with clinical or pathological stage iii or iv, or recurrent disease; and
Descrizione

nsclc stage III or IV

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0278506
UMLS CUI [2]
C0278987
UMLS CUI [3]
C0278517
2. hemoglobin level at or below 120 g/l; and
Descrizione

hemoglobin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0518015
3. at least 18 years of age;
Descrizione

age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. systemic platinum-based chemotherapy for lung cancer during the previous two months or planned platinum-based chemotherapy within the next three months;
Descrizione

systemic platinum-based chemotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C2266918
2. patients previously treated with high dose thoracic radiation (>10 fractions), or surgery, without objective evidence of disease recurrence;
Descrizione

previous RTx or surgery, no evidenc of disease recurrence

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0279134
UMLS CUI [2]
C0744961
UMLS CUI [3]
C0277556
3. planned high dose thoracic radiation therapy (>10 fractions);
Descrizione

planned high dose thoracic radiation therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1514710
4. a clinically active malignancy, other than the underlying lung cancer which is expected to influence qol;
Descrizione

clinically active malignancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006826
5. expected survival of three months or less;
Descrizione

life expectancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023671
6. ecog performance status of 3 or 4 (see appendix d);
Descrizione

ecog performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
7. multiple cns metastasis or a single cns lesion that does not demonstrate radiographic stability (screening ct of head required only if symptomatic, no radiographic follow-up of single resected lesions required);
Descrizione

cns metastasis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0686377
8. blood transfusions within the last 14 days;
Descrizione

blood transfusions

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005841
9. previous use of erythropoietin;
Descrizione

previous use of erythropoietin

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0199970
10. anemia due to factors other than cancer / radiotherapy (e.g. hemolysis or gastrointestinal bleeding);
Descrizione

anemia

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0002871
11. evidence of untreated folate or vitamin b12 deficiency;
Descrizione

evidence of untreated folate or vitamin b12 deficiency

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0042847
UMLS CUI [2]
C0016412
12. history of uncontrolled hypertension or diastolic blood pressure greater than 100 mm hg;
Descrizione

uncontrolled hypertension or diastolic blood pressure

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2]
C0235222
13. history of seizure disorder;
Descrizione

seizure disorder

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0014544
14. known hypersensitivity to mammalian cell-derived products, albumin or any component of the study drug;
Descrizione

hypersensitivity to mammalian cell-derived products, albumin or any component of the study drug

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013182
15. pregnancy, lactation or parturition within the previous 30 days;
Descrizione

pregnancy, lactation or parturition

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C1148523
16. unwillingness or inability to complete the required qol questionnaires;
Descrizione

compliance

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1321605
17. mental incompetence, including psychiatric or addictive disorders which would preclude meaningful completion of questionnaires;
Descrizione

condition precluding study compliance

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
18. geographically inaccessible for treatment or follow-up evaluations;
Descrizione

geographically inaccessible for treatment or follow-up evaluations

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0814423
19. currently enrolled in an ongoing therapeutic study;
Descrizione

study participation status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
Ritorna all'inizio della pagina

Similar models

Eligibility Non-Small-Cell Lung Carcinoma NCT00310232

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
nsclc stage III or IV
Item
1. histologically confirmed non-small cell lung cancer (squamous cell, large cell, adenocarcinoma, or some combination of these), with clinical or pathological stage iii or iv, or recurrent disease; and
boolean
C0278506 (UMLS CUI [1])
C0278987 (UMLS CUI [2])
C0278517 (UMLS CUI [3])
hemoglobin
Item
2. hemoglobin level at or below 120 g/l; and
boolean
C0518015 (UMLS CUI [1])
age
Item
3. at least 18 years of age;
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
systemic platinum-based chemotherapy
Item
1. systemic platinum-based chemotherapy for lung cancer during the previous two months or planned platinum-based chemotherapy within the next three months;
boolean
C0392920 (UMLS CUI [1,1])
C2266918 (UMLS CUI [1,2])
previous RTx or surgery, no evidenc of disease recurrence
Item
2. patients previously treated with high dose thoracic radiation (>10 fractions), or surgery, without objective evidence of disease recurrence;
boolean
C0279134 (UMLS CUI [1])
C0744961 (UMLS CUI [2])
C0277556 (UMLS CUI [3])
planned high dose thoracic radiation therapy
Item
3. planned high dose thoracic radiation therapy (>10 fractions);
boolean
C1514710 (UMLS CUI [1])
clinically active malignancy
Item
4. a clinically active malignancy, other than the underlying lung cancer which is expected to influence qol;
boolean
C0006826 (UMLS CUI [1])
life expectancy
Item
5. expected survival of three months or less;
boolean
C0023671 (UMLS CUI [1])
ecog performance status
Item
6. ecog performance status of 3 or 4 (see appendix d);
boolean
C1520224 (UMLS CUI [1])
cns metastasis
Item
7. multiple cns metastasis or a single cns lesion that does not demonstrate radiographic stability (screening ct of head required only if symptomatic, no radiographic follow-up of single resected lesions required);
boolean
C0686377 (UMLS CUI [1])
blood transfusions
Item
8. blood transfusions within the last 14 days;
boolean
C0005841 (UMLS CUI [1])
previous use of erythropoietin
Item
9. previous use of erythropoietin;
boolean
C0199970 (UMLS CUI [1])
anemia
Item
10. anemia due to factors other than cancer / radiotherapy (e.g. hemolysis or gastrointestinal bleeding);
boolean
C0002871 (UMLS CUI [1])
evidence of untreated folate or vitamin b12 deficiency
Item
11. evidence of untreated folate or vitamin b12 deficiency;
boolean
C0042847 (UMLS CUI [1])
C0016412 (UMLS CUI [2])
uncontrolled hypertension or diastolic blood pressure
Item
12. history of uncontrolled hypertension or diastolic blood pressure greater than 100 mm hg;
boolean
C1868885 (UMLS CUI [1])
C0235222 (UMLS CUI [2])
seizure disorder
Item
13. history of seizure disorder;
boolean
C0014544 (UMLS CUI [1])
hypersensitivity to mammalian cell-derived products, albumin or any component of the study drug
Item
14. known hypersensitivity to mammalian cell-derived products, albumin or any component of the study drug;
boolean
C0013182 (UMLS CUI [1])
pregnancy, lactation or parturition
Item
15. pregnancy, lactation or parturition within the previous 30 days;
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C1148523 (UMLS CUI [3])
compliance
Item
16. unwillingness or inability to complete the required qol questionnaires;
boolean
C1321605 (UMLS CUI [1])
condition precluding study compliance
Item
17. mental incompetence, including psychiatric or addictive disorders which would preclude meaningful completion of questionnaires;
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
geographically inaccessible for treatment or follow-up evaluations
Item
18. geographically inaccessible for treatment or follow-up evaluations;
boolean
C0814423 (UMLS CUI [1])
study participation status
Item
19. currently enrolled in an ongoing therapeutic study;
boolean
C2348568 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial